REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/03/2025
Voltar para busca
Dado oficial do USPTO
ORTHOCELL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ORTHOCELL
ST13
US500000079246526Classe
5, 42, 44
Pedido
79246526
Registro
6004489
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
10/03/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
24/10/2018
Data de registro
10/03/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/03/2020
Última transação
10/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
AU
Examinador
O'BRIEN, JENNIFER
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Orthocell Limited
Representantes
Matthew J. Stark Price Heneveld LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Stem cells for medical purposes; collagen for medical use; biodegradable implants comprising biological material being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; implant materials comprising biological material being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration in surgery; implantable materials comprising biological material being living cells and implantable scaffolds comprising biological materials for use in guided tissue regeneration; implants comprising biological material being living cells and implantable scaffolds comprising biological materials for guided tissue regeneration; surgical implants comprised of living cells; therapeutic agentstherapeutic agents for tissue regeneration; therapeutic biological productsbiological cell cultures for medical purposesBiological tissue graftsBiological preparations for guided tissue regeneration; medical preparations for the treatment of tissue repair; guided tissue regeneration materialsimplants comprising biological materials being living cells and implantable scaffolds comprising biological materials; biological preparations for medical purposes for use in guided tissue regeneration for tissue repair; tissue-regenerative medical preparations for use in guided tissue regeneration of damaged tissue; biological materials for medical usesurgical implants comprised of living cellsBiological tissue graftsBiological materials for medical purposes being living cells and implantable scaffolds comprising biological materials; Collagen for medical purposescollagen based scaffolding for biomechanical support and stabilisation; Cells for medical or clinical usecellular therapeutic tendon and cartilage regeneration products
Classe 42
Medical research; scientific and technological servicesproduct research and development relating to tissue regeneration products and techniques in the field of biomechanical and cellular therapeutic medical techniques; scientific research relating to biology; scientific and technological research and design services relating to biomechanical and cellular therapeutic medical techniques
Classe 44
Advisory services relating to medical services; medical services; medical advisory services; medical care services; medical health assessment services; medical treatment services of regeneration of damaged tissue and for tissue repair; provision of medical information; provision of medical services; medical servicesincluding those relating to biomechanical and cellular therapeutic medical techniques
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/08/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
19/07/2020
FIMP
FINAL DISPOSITION PROCESSED
19/07/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/06/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
10/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/12/2019
PUBO
PUBLISHED FOR OPPOSITION
24/12/2019
GPNX
NOTIFICATION PROCESSED BY IB
20/12/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/12/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/12/2019
ALIE
ASSIGNED TO LIE
15/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
29/10/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
29/10/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
29/10/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
29/10/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
23/09/2019
GNFR
FINAL REFUSAL E-MAILED
23/09/2019
CNFR
FINAL REFUSAL WRITTEN
23/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/08/2019
RFNT
REFUSAL PROCESSED BY IB
02/03/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/02/2019
RFRR
REFUSAL PROCESSED BY MPU
12/02/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/02/2019
CNRT
NON-FINAL ACTION WRITTEN
05/02/2019
DOCK
ASSIGNED TO EXAMINER
31/01/2019
MAFR
APPLICATION FILING RECEIPT MAILED
04/12/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/11/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/11/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ORTHOCELL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.